image of a green circle Annotated and expert reviewed. Please contact us if you can help with updates. 

FZD2

Family: Frizzleds

Contents:
Gene and Protein Information
Previous and Unofficial Names
Database Links
Agonists
Transduction Mechanisms
Tissue Distribution
Expression Datasets
Functional Assays
Physiological Consequences of Altering Gene Expression
Phenotypes, Alleles and Disease Models
General Comments
References
Gene and Protein Information
Frizzled family G protein-coupled receptor
Species TM AA Chromosomal Location Gene Symbol Gene Name Reference
Human 7 565 17q21.1 FZD2 frizzled family receptor 2 13
Mouse 7 570 11 E1 Fzd2 frizzled homolog 2 (Drosophila) 5
Rat 7 570 10q32.1 Fzd2 frizzled family receptor 2 2
Previous and Unofficial Names
frizzled homolog 2 (Drosophila)
Fz2
Hfz2
hFz2
Frizzled-2
frizzled (Drosophila) homolog 2
frizzled 2, seven transmembrane spanning receptor
Fz-10
Fzd10
Drosophila polarity gene (frizzled) homologue
Drosophila polarity gene homolog 2
frizzled family receptor 2
frizzled homolog 2
fz-2
rFz2
Mfz10
Mfz10a
Fz10
AW456835
Database Links
Ensembl
Entrez Gene
GeneCards
GenitoUrinary Development Molecular Anatomy Project
HomoloGene
Human Protein Reference Database
InterPro
KEGG Gene
OMIM
PharmGKB Gene
PhosphoSitePlus
Protein Ontology (PRO)
RefSeq Nucleotide
RefSeq Protein
TreeFam
UniGene Hs.
UniProt
Wikipedia
Search for 3D structures on the PDB
Search by keyword: Frizzleds FZD2
Natural/Endogenous Ligand(s)
Wnt-5a {Sp: Human}
Agonist Comments
Endogenous protein WNT-5A binds to the FZD2 receptor [1,3-4].

Due to the lack of purified and biologically active WNTs hardly any information on the specificity and pharmacology of FZD-WNT interaction is available. Extensive and quantitative binding assays have not been performed with mammalian FZDs. The references above contain data showing the direct activation/interaction of FZD2 by individual WNTs.
Primary Transduction Mechanisms
Transducer Effector/Response
Gi/Go family Other - See Comments
Comments:  Even though data argue strongly for FZD2 signalling via heterotrimeric G proteins, no direct interaction between FZD2 and the G protein has been shown yet. Thus direct proof for G protein-coupling of this receptor is still not available.
References:  1,3-4
Tissue Distribution
Adult heart, fetal brain, lung, kidney.
Species:  Human
Technique:  Northern blotting.
References:  6
Arthritic synovial tissue.
Species:  Human
Technique:  RT-PCR.
References:  8
Fetal brain, lung, kidney, adult heart, skeletal muscle, ovary, testis, pancreas > fetal liver, adult lung, liver, prostate, colon, small intestine > adult brain, placenta, spleen, leukocytes, thymus.
Species:  Human
Technique:  Northern blotting.
References:  13
Developing mouse thoracic arterial system and heart.
Species:  Mouse
Technique:  Whole mount in situ hybridisation.
References:  10
Brain, eye, heart, kidney, lung, spleen, testis.
Species:  Mouse
Technique:  Northern blotting.
References:  11
Adult: kidney, liver, uterus, ovary, heart > brain, small intestine > calvaria, lung, mammary gland, testis.
Species:  Rat
Technique:  Northern blotting.
References:  2
Expression Datasets

Click here to show/hide data

Log average relative transcript abundance in mouse tissues measured by qPCR from Regard, J.B., Sato, I.T., and Coughlin, S.R. (2008). Anatomical profiling of G protein-coupled receptor expression. Cell, 135(3): 561-71. [PMID:18984166] [Raw data: website]

There should be a chart of expression data here, you may need to enable JavaScript!
Functional Assays
Measurement of cGMP levels in mouse F9 teratocarcinoma cells expressing the rat FZD2 receptor.
Species:  Rat
Tissue:  Mouse F9 cells.
Response measured:  WNT-5A conditioned medium-induced decrease in cGMP levels.
References:  1
Measurement of intracellular Ca2+ levels, NFAT-reporter activity and PKG activity via Gt2 and Go in mouse F9 teratocarcinoma cells expressing the rat FZD2 receptor.
Species:  Rat
Tissue:  Mouse F9 cells.
Response measured:  WNT-5A-induced and PTX-sensitive increase in Ca2+ mobilisation, NFAT-reporter activity and PKG activity.
References:  3
Measurement of ATF-2 phosphorylation, p38 kinase activity and phosphorylation, PKG activity and cGMP levels, intracellular Ca2+ mobilisation and PDE activity in mouse F9 cells and HEK 293 cells expressing the rat FXD2 receptor.
Species:  Rat
Tissue:  Mouse F9 cells, HEK 293 cells.
Response measured:  WNT-5A-induced, PTX-sensitive increase in ATF-2 phosphorylation, p38 activity/phosphorylation, decrease in PKG activity and cGMP levels, mobilisation of Ca2+ and increase in PDE activity.
References:  4
Physiological Consequences of Altering Gene Expression
FZD2 receptor knockout mice are viable and normal.
Species:  Mouse
Tissue: 
Technique:  Transgenesis.
References:  9
Phenotypes, Alleles and Disease Models Mouse data from MGI

Click here to show/hide data

Allele Composition & genetic background Accession Phenotype Id Phenotype Reference
Fzd1tm1.1Nat|Fzd2tm1.1Nat Fzd1tm1.1Nat/Fzd1tm1.1Nat,Fzd2tm1.1Nat/Fzd2tm1.1Nat
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
MGI:1196625  MGI:1888513  MP:0002622 abnormal cochlear hair cell morphology PMID: 20940229 
Fzd2tm1.1Nat|Vangl2+|Vangl2Lp Fzd2tm1.1Nat/Fzd2tm1.1Nat,Vangl2Lp/Vangl2+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * LPT/LeJ
MGI:1888513  MGI:2135272  MP:0002622 abnormal cochlear hair cell morphology PMID: 20940229 
Fzd1tm1.1Nat|Fzd2tm1.1Nat Fzd1tm1.1Nat/Fzd1tm1.1Nat,Fzd2tm1.1Nat/Fzd2tm1.1Nat
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
MGI:1196625  MGI:1888513  MP:0004406 abnormal cochlear hair cell number PMID: 20940229 
Fzd2tm1.1Nat|Vangl2+|Vangl2Lp Fzd2tm1.1Nat/Fzd2tm1.1Nat,Vangl2Lp/Vangl2+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * LPT/LeJ
MGI:1888513  MGI:2135272  MP:0004406 abnormal cochlear hair cell number PMID: 20940229 
Fzd1tm1.1Nat|Fzd2tm1.1Nat Fzd1tm1.1Nat/Fzd1tm1.1Nat,Fzd2tm1.1Nat/Fzd2tm1.1Nat
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
MGI:1196625  MGI:1888513  MP:0000266 abnormal heart morphology PMID: 20940229 
Fzd1tm1.1Nat|Fzd2+|Fzd2tm1.1Nat Fzd1tm1.1Nat/Fzd1tm1.1Nat,Fzd2tm1.1Nat/Fzd2+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
MGI:1196625  MGI:1888513  MP:0000266 abnormal heart morphology PMID: 20940229 
Fzd1+|Fzd1tm1.1Nat|Fzd2tm1.1Nat Fzd1tm1.1Nat/Fzd1+,Fzd2tm1.1Nat/Fzd2tm1.1Nat
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
MGI:1196625  MGI:1888513  MP:0000266 abnormal heart morphology PMID: 20940229 
Fzd1tm1.1Nat|Fzd2tm1.1Nat Fzd1tm1.1Nat/Fzd1tm1.1Nat,Fzd2tm1.1Nat/Fzd2tm1.1Nat
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
MGI:1196625  MGI:1888513  MP:0000452 abnormal mouth morphology PMID: 20940229 
Fzd2tm1.1Nat Fzd2tm1.1Nat/Fzd2tm1.1Nat
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
MGI:1888513  MP:0002272 abnormal nervous system electrophysiology PMID: 20940229 
Fzd2tm1.1Nat Fzd2tm1.1Nat/Fzd2tm1.1Nat
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
MGI:1888513  MP:0001983 abnormal olfactory system physiology PMID: 20940229 
Fzd1tm1.1Nat|Fzd2tm1.1Nat Fzd1tm1.1Nat/Fzd1tm1.1Nat,Fzd2tm1.1Nat/Fzd2tm1.1Nat
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
MGI:1196625  MGI:1888513  MP:0004491 abnormal orientation of outer hair cell stereociliary bundles PMID: 20940229 
Fzd2tm1.1Nat|Vangl2+|Vangl2Lp Fzd2tm1.1Nat/Fzd2tm1.1Nat,Vangl2Lp/Vangl2+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * LPT/LeJ
MGI:1888513  MGI:2135272  MP:0004491 abnormal orientation of outer hair cell stereociliary bundles PMID: 20940229 
Fzd1tm1.1Nat|Fzd2tm1.1Nat Fzd1tm1.1Nat/Fzd1tm1.1Nat,Fzd2tm1.1Nat/Fzd2tm1.1Nat
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
MGI:1196625  MGI:1888513  MP:0009653 abnormal palate development PMID: 20940229 
Fzd1tm1.1Nat|Fzd2tm1.1Nat Fzd1tm1.1Nat/Fzd1tm1.1Nat,Fzd2tm1.1Nat/Fzd2tm1.1Nat
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
MGI:1196625  MGI:1888513  MP:0000111 cleft palate PMID: 20940229 
Fzd1tm1.1Nat|Fzd2+|Fzd2tm1.1Nat Fzd1tm1.1Nat/Fzd1tm1.1Nat,Fzd2tm1.1Nat/Fzd2+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
MGI:1196625  MGI:1888513  MP:0000111 cleft palate PMID: 20940229 
Fzd2tm1.1Nat Fzd2tm1.1Nat/Fzd2tm1.1Nat
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
MGI:1888513  MP:0000111 cleft palate PMID: 20940229 
Fzd2tm1.1Nat|Vangl2+|Vangl2Lp Fzd2tm1.1Nat/Fzd2tm1.1Nat,Vangl2Lp/Vangl2+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * LPT/LeJ
MGI:1888513  MGI:2135272  MP:0000111 cleft palate PMID: 20940229 
Fzd1tm1.1Nat|Fzd2tm1.1Nat Fzd1tm1.1Nat/Fzd1tm1.1Nat,Fzd2tm1.1Nat/Fzd2tm1.1Nat
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
MGI:1196625  MGI:1888513  MP:0001575 cyanosis PMID: 20940229 
Fzd2tm1.1Nat Fzd2tm1.1Nat/Fzd2tm1.1Nat
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
MGI:1888513  MP:0001265 decreased body size PMID: 20940229 
Fzd1tm1.1Nat|Fzd2tm1.1Nat Fzd1tm1.1Nat/Fzd1tm1.1Nat,Fzd2tm1.1Nat/Fzd2tm1.1Nat
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
MGI:1196625  MGI:1888513  MP:0000284 double outlet heart right ventricle PMID: 20940229 
Fzd1tm1.1Nat|Fzd2tm1.1Nat Fzd1tm1.1Nat/Fzd1tm1.1Nat,Fzd2tm1.1Nat/Fzd2tm1.1Nat
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
MGI:1196625  MGI:1888513  MP:0009886 failure of palatal shelf elevation PMID: 20940229 
Fzd2tm1.1Nat Fzd2tm1.1Nat/Fzd2tm1.1Nat
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
MGI:1888513  MP:0002058 neonatal lethality PMID: 20940229 
Fzd1+|Fzd1tm1.1Nat|Fzd2+|Fzd2tm1.1Nat|Vangl2+|Vangl2Lp Fzd1tm1.1Nat/Fzd1+,Fzd2tm1.1Nat/Fzd2+,Vangl2Lp/Vangl2+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * LPT/LeJ
MGI:1196625  MGI:1888513  MGI:2135272  MP:0000929 open neural tube PMID: 20940229 
Fzd2tm1.1Nat|Vangl2+|Vangl2Lp Fzd2tm1.1Nat/Fzd2tm1.1Nat,Vangl2Lp/Vangl2+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * LPT/LeJ
MGI:1888513  MGI:2135272  MP:0000929 open neural tube PMID: 20940229 
Fzd1tm1.1Nat|Fzd2tm1.1Nat Fzd1tm1.1Nat/Fzd1tm1.1Nat,Fzd2tm1.1Nat/Fzd2tm1.1Nat
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
MGI:1196625  MGI:1888513  MP:0000273 overriding aorta PMID: 20940229 
Fzd1tm1.1Nat|Fzd2tm1.1Nat Fzd1tm1.1Nat/Fzd1tm1.1Nat,Fzd2tm1.1Nat/Fzd2tm1.1Nat
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
MGI:1196625  MGI:1888513  MP:0009888 palatal shelves fail to meet at midline PMID: 20940229 
Fzd1tm1.1Nat|Fzd2tm1.1Nat Fzd1tm1.1Nat/Fzd1tm1.1Nat,Fzd2tm1.1Nat/Fzd2tm1.1Nat
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
MGI:1196625  MGI:1888513  MP:0000088 short mandible PMID: 20940229 
Fzd1tm1.1Nat|Fzd2tm1.1Nat Fzd1tm1.1Nat/Fzd1tm1.1Nat,Fzd2tm1.1Nat/Fzd2tm1.1Nat
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
MGI:1196625  MGI:1888513  MP:0010402 ventricular septal defect PMID: 20940229 
Fzd1+|Fzd1tm1.1Nat|Fzd2+|Fzd2tm1.1Nat|Vangl2+|Vangl2Lp Fzd1tm1.1Nat/Fzd1+,Fzd2tm1.1Nat/Fzd2+,Vangl2Lp/Vangl2+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * LPT/LeJ
MGI:1196625  MGI:1888513  MGI:2135272  MP:0010402 ventricular septal defect PMID: 20940229 
Fzd2tm1.1Nat|Vangl2+|Vangl2Lp Fzd2tm1.1Nat/Fzd2tm1.1Nat,Vangl2Lp/Vangl2+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * LPT/LeJ
MGI:1888513  MGI:2135272  MP:0010402 ventricular septal defect PMID: 20940229 
General Comments
The WNTs that are available in purified and active form for a pharmacological characterisation to date are WNT-3A and WNT-5A [7,12].

FZD2 (mouse) shows high homology to FZD10 (mouse). Since these receptors are encoded by two genes on different chromosomes, they should be seen as two receptor subtypes.

REFERENCES

To cite this database page, please use the following:

Jacomijn Dijksterhuis, Matthias Lauth, Tilman Polonio, Gunnar Schulte.
Frizzleds: FZD2. Last modified on 16/01/2013. Accessed on 21/05/2013. IUPHAR database (IUPHAR-DB), http://www.iuphar-db.org/DATABASE/ObjectDisplayForward?objectId=230.


Contact us | Print | Back to top | Help